|
Licensing, supply and distribution of five other obstetrical drugs as reported by drug information officers or drug regulatory officials – survey |
|||
| Country/drug |
Licensed |
Problems with supply or distribution |
Comments |
|
|
|||
| Armenia |
|||
| Folic acid |
Yes |
No |
|
| Ergometrin |
Yes |
No |
The registered form is methylergometrine. |
| Oxytocin |
Yes |
No |
|
| Hydralazine |
No |
Yes |
There is a demand for the drug, but no interest from drug companies. |
| Nevirapine |
Yes |
Yes |
There is a demand for the drug, but no interest from drug companies. |
| Bolivia |
|||
| Folic acid |
Yes & No |
Yes |
Availability problems within the public health services (logistical). |
| Ergometrin |
No |
No |
|
| Oxytocin |
No |
No |
|
| Hydralazine |
No |
Yes |
Not available in the national market. Only imported by two suppliers for use in public health facilities. |
| Nevirapine |
Yes |
Yes |
Not on national EML & not registered so not available on the national market. AZT is available but expensive. |
| Cambodia |
|||
| Folic acid |
Yes |
No |
|
| Ergometrin |
Yes |
Yes |
There are often shortages due to short shelf-life. |
| Oxytocin |
Yes |
No |
|
| Hydralazine |
Yes |
Yes |
There are often shortages due to short shelf-life. |
| Nevirapine |
No |
DN |
Not available in Cambodia. |
| India |
|||
| Folic acid |
NR |
No |
|
| Ergometrin |
NR |
No |
|
| Oxytocin |
NR |
No |
|
| Hydralazine |
NR |
Yes |
Low demand as a better therapeutic alternative is available. Produced by one manufacturer only. |
| Nevirapine |
NR |
Yes & No |
|
| Indonesia |
|||
| Folic acid |
No |
No |
|
| Ergometrin |
No |
No |
|
| Oxytocin |
No |
No |
|
| Hydralazine |
No |
No |
|
| Nevarapine |
DN |
DN |
Only been registered in 2002 so too early to know if there are any problems with supply. |
| Iran |
|||
| Folic acid |
Yes |
No |
|
| Ergometrin |
Yes |
No |
|
| Oxytocin |
Yes |
No |
|
| Hydralazine |
Yes |
No |
|
| Nevirapine |
No |
Yes |
This drug is not being used in Iran. |
| Philippines |
|||
| Folic acid |
Yes |
No |
|
| Ergometrin |
Yes |
No |
|
| Oxytocin |
Yes |
No |
|
| Hydralazine |
Yes |
No |
|
| Nevirapine |
No |
NR |
Not registered by the Bureau of Food & Drugs. |
| Rwanda |
|||
| Folic acid |
Yes |
No |
|
| Ergometrin |
DN |
No |
|
| Oxytocin |
Yes |
No |
|
| Hydralazine |
Yes |
Yes |
Many health facilities of out of stock. |
| Nevirapine |
Yes |
No |
|
| Yemen |
|||
| Folic acid |
Yes |
DN |
|
| Ergometrin |
Yes |
DN |
|
| Oxytocin |
Yes |
DN |
|
| Hydralazine |
DN |
DN |
|
| Nevirapine |
DN |
DN |
No cases. |
|
DN = do not know NR = not reported | |||
Aaserud et al. BMC Health Services Research 2005 5:68 doi:10.1186/1472-6963-5-68 |
|||